FI52725B - - Google Patents

Info

Publication number
FI52725B
FI52725B FI2935/69A FI293569A FI52725B FI 52725 B FI52725 B FI 52725B FI 2935/69 A FI2935/69 A FI 2935/69A FI 293569 A FI293569 A FI 293569A FI 52725 B FI52725 B FI 52725B
Authority
FI
Finland
Application number
FI2935/69A
Other languages
Finnish (fi)
Other versions
FI52725C (en
Inventor
Karl-Heinz Boltze
Dietrich Lorenz
Original Assignee
Troponwerke Dinklage & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Troponwerke Dinklage & Co filed Critical Troponwerke Dinklage & Co
Publication of FI52725B publication Critical patent/FI52725B/fi
Application granted granted Critical
Publication of FI52725C publication Critical patent/FI52725C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01FMAGNETS; INDUCTANCES; TRANSFORMERS; SELECTION OF MATERIALS FOR THEIR MAGNETIC PROPERTIES
    • H01F27/00Details of transformers or inductances, in general

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Power Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI692935A 1968-10-16 1969-10-13 Process for the preparation of 2-methyl-3- (3- (e-phenylpiperazinyl) (1) -2-hydroxypropyl) -quinazolinone- (4) having analgesic and anticitatory activity. FI52725C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19681803210 DE1803210A1 (en) 1968-10-16 1968-10-16 2-Methyl-3- (3- [4-phenylpiperazinyl- (1)] -2-hydroxypropyl) -quinazolinone- (4) and process for its preparation

Publications (2)

Publication Number Publication Date
FI52725B true FI52725B (en) 1977-08-01
FI52725C FI52725C (en) 1977-11-10

Family

ID=5710568

Family Applications (1)

Application Number Title Priority Date Filing Date
FI692935A FI52725C (en) 1968-10-16 1969-10-13 Process for the preparation of 2-methyl-3- (3- (e-phenylpiperazinyl) (1) -2-hydroxypropyl) -quinazolinone- (4) having analgesic and anticitatory activity.

Country Status (7)

Country Link
US (1) US3652567A (en)
CH (1) CH531524A (en)
DE (1) DE1803210A1 (en)
FI (1) FI52725C (en)
FR (1) FR2020814B1 (en)
GB (1) GB1245316A (en)
SE (1) SE378422B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1936588A1 (en) * 1969-07-18 1971-02-18 Troponwerke Dinklage & Co Pharmacologically active quinazolinone compound, its use in pharmacological preparations and process for its manufacture
US3879393A (en) * 1973-06-18 1975-04-22 Miles Lab Derivatives of 1,3-disubstituted 2,4(1h,3h)-quinazolinediones
DE4203050C2 (en) * 1992-02-04 1994-03-17 Heiko Delecate Electric motor assembly and air motor assembly
TW200306839A (en) 2002-02-06 2003-12-01 Novartis Ag Quinazolinone derivatives and their use as CB agonists
GB0413618D0 (en) * 2004-06-17 2004-07-21 Novartis Ag Organic compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3231572A (en) * 1963-08-05 1966-01-25 Miles Lab 3-substituted-4-quinazolones

Also Published As

Publication number Publication date
DE1803210A1 (en) 1970-05-14
FR2020814A1 (en) 1970-07-17
US3652567A (en) 1972-03-28
SE378422B (en) 1975-09-01
CH531524A (en) 1972-12-15
GB1245316A (en) 1971-09-08
FI52725C (en) 1977-11-10
FR2020814B1 (en) 1974-02-01

Similar Documents

Publication Publication Date Title
AU428130B2 (en)
AU5184069A (en)
AU6168869A (en)
FI52725B (en)
AU6171569A (en)
AU416157B2 (en)
AU429879B2 (en)
AU4811568A (en)
AU421558B1 (en)
AU3789668A (en)
AU4744468A (en)
AU3224368A (en)
BE725153A (en)
BE709446A (en)
BE726798A (en)
AU479894A (en)
BE709274A (en)
AU479393A (en)
BE726349A (en)
BE726007A (en)
BE709301A (en)
BE721926A (en)
BE727380A (en)
AU463027A (en)
BE709496A (en)